Inventor · disambiguated record
Svitlana Kulyk
Also filed as: KULYK SVITLANA
12 granted patents·17 pending applications·7 citations·filing 2019–2025
84Inventor score
Top patents by PatentIndex Score
29 records- 0192US12421253B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·1 cites·29 claims
- 0289US11999753B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·1 cites·5 claims
- 0384US11590116B2Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 28, 2023·1 cites·25 claims
- 0484US11479551B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Oct 25, 2022·1 cites·30 claims
- 0583US12145948B2Compounds and methods for modulating HER2IAMBIC THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·1 cites·27 claims
- 0683US10952996B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·20 claims
- 0777US12304915B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·81 claims
- 0875US2025270220A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0972US2023054883A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1071US2025276983A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1171US2023399312A1Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1270US2025388606A1Azaquinazoline pan-kras inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1370US2023218597A1Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1468US12398154B2Azaquinazoline pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Aug 26, 2025·0 cites·49 claims
- 1568US11492351B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·0 cites·27 claims
- 1667US11702418B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·72 claims
- 1767US2024132521A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1866US2025382290A1Salts of sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1965US11673879B2Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Jun 13, 2023·0 cites·23 claims
- 2064US2025368649A1Tetrahydropyridopyrimidine pan-kras inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2164US2024025907A1QUINAZOLINE PAN-KRas INHIBITORSMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2263US2024270719A1Crystalline forms of 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrileMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2362US11730720B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Aug 22, 2023·0 cites·28 claims
- 2459US2024368153A1Aminopyridine-based MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2559US2025059182A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2657US2024208912A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2748US2025019367A1Methods for Separation of EnantiomersMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2838US2025276984A1Solid state forms of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2936US2025345339A1Doses and regimens of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Svitlana Kulyk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →